home / stock / cvrx / cvrx news

CVRX News and Press, CVRx Inc. From 01/09/23

Stock Information
Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com
Menu
CVRX CVRX Quote CVRX Short CVRX News CVRX Articles CVRX Message Board
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CVRX - CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain preliminary ...
CVRX - CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 28, 2022 (GLOBE NEWSWIRE) --  CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the ...

CVRX - CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference

MINNEAPOLIS, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”),  a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that ...

CVRX - CVRx Launches new Barostim NEO2(TM) Implantable Pulse Generator

The new Barostim NEO2 Implantable Pulse Generator (IPG) launches in the U.S., improving the patient experience while on therapy and simplifying the implant procedure for physicians MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), devel...
CVRX - CVRx to Attend Upcoming Investor Conferences

MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the ...

CVRX - CVRx, Inc. (CVRX) Q3 2022 Earnings Call Transcript

CVRx, Inc. (CVRX) Q3 2022 Earnings Conference Call November 01, 2022, 05:30 PM ET Company Participants Mike Vallie - Westwicke, ICR Company Nadim Yared - President and CEO Jared Oasheim - CFO Conference Call Participants Matthew O'Brien - Piper Sandle...

CVRX - CVRx GAAP EPS of -$0.48 beats by $0.08, revenue of $6.2M beats by $0.52M

CVRx press release ( NASDAQ: CVRX ): Q3 GAAP EPS of -$0.48 beats by $0.08 . Revenue of $6.2M (+82.4% Y/Y) beats by $0.52M . Shares +3.8% . For the full year of 2022, the Company now expects: Total revenue between $21.8 million and $22.3 mil...
CVRX - CVRx Reports Third Quarter 2022 Financial and Operating Results

MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial ...

CVRX - CVRx to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call on November 1st, 2022

MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans ...

CVRX - CVRx Pursues Revenue Growth But Operating Losses Worsen

CVRx went public in June 2021, raising approximately $126 million in an IPO. The company is commercializing its neuromodulation cardiovascular medical device and related products. CVRx is growing revenue from a tiny base but is generating high operating losses and faces a variety ...
Previous 10 Next 10